Mechanisms involved in agonist-induced hyperaggregability of platelets from normal pregnancy

Journal of Biomedical Science

Volumn 9, Issue 1, 2002, Pages 17-25

  Sheu, Joen Rong ^a   Hsiao, George ^a   Lin, Wen Yi ^a   Chen, Tzeng Fu ^a   Chien, Yi Yi ^a   Lin, Chien Huang ^a   Tzeng, Chiu Ruey ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cyclic AMP; Hyperaggregability; Normal pregnancy; Platelets; Thromboxane A2

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ARACHIDONIC ACID; COLLAGEN; CYCLIC AMP; CYCLIC GMP; FIBRINOGEN RECEPTOR; FLUORESCEIN ISOTHIOCYANATE; FURA 2 ACETOXYMETHYL ESTER; IMIDAZOLE; NITRATE; NITRIC OXIDE; PROSTAGLANDIN E1; PROSTAGLANDIN E2; THROMBOXANE A2; THROMBOXANE B2; TRIFLAVIN;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME RELEASE; FEMALE; GESTATIONAL AGE; HUMAN; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADENOSINE TRIPHOSPHATE; ADULT; BLOOD PLATELETS; CALCIUM SIGNALING; COLLAGEN; CYCLIC AMP; DINOPROSTONE; FEMALE; HUMANS; IMIDAZOLES; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELET TRANSFUSION; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; THROMBOXANE A2; THROMBOXANE-A SYNTHASE;

EID: 0036159918     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1159/000048195     Document Type: Article

References (28)

1. SQ22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitor
2. Systemic and fetal-maternal nitric oxide synthesis in normal pregnancy and pre-eclampsia
3. The aggregation of blood platelets
4. Inhibition of platelet secretion by an antagonist of intracellular calcium
5. 2 synthesis in patients with diabetes mellitus
6. Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets
7. 2+ indicators with greatly improved fluorescence properties
8. Is routine antenatal care worthwhile?
9. A cross-sectional study of platelet cyclic AMP in healthy and hypertensive pregnancy
10. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom
11. Prostaglandins: Specific inhibition of platelet adhesion to collagen and relationship with cAMP level
12. A longitudinal study of platelet behaviour and thromboxane production in whole blood in normal pregnancy and the puerperium
13. 2 production in non-pregnant women, in normal pregnancy, and in gestational hypertension
14. Protein measurement with the Folin phenol reagent
15. Nitric oxide and cyclic GMP signaling
16. Identification of constitutive and inducible forms of nitric oxide synthase in human platelets
17. Platelet behaviour in normal pregnancy, pregnancy complicated by essential hypertension and pregnancy-induced hypertension
18. Prediction of pre-eclampsia
19. Maternal and fetal platelet activation in normal pregnancy
20. Platelets and the beginnings of preeclampsia
21. Mechanisms involved in the antiplatelet activity of Escherichia coli lipopolysaccharide in human platelets
22. Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia
23. The antiplatelet activity of PMC a potent α-tocopherol analogue, is mediated through inhibition of cyclooxygenase
24. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells
25. Triflavin, an RGD-containing antiplatelet peptide, binds to GpIIIa of ADP-stimulated platelets
26. Platelet cyclic GMP. A potentially useful indicator to evaluate the effects of nitroglycerin and nitrate tolerance
27. 2 in pregnancy and puerperium
28. 2+ in platelets is controlled by cyclic AMP: Antagonism between stimulators and inhibitors of adenylate cyclase